Patients with diabetes mellitus are at high risk for both heart failure and ischemic events. Sodium–glucose cotransporter 2 (SGLT2) inhibitors have been shown to be effective for the treatment of type 2 diabetes mellitus and to lower the risk of hospitalization for heart failure among patients with…
No comments:
Post a Comment